Adverse reactions to antibiotics send thousands of patients to the ERAugust 13, 2008Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases. "This number is an important reminder for physicians and patients that antibiotics can have serious side effects and should only be taken when necessary," said study author Daniel Budnitz, M.D., at the Centers for Disease Control and Prevention (CDC). Prior to this study, detailed data on the scope and burden of antibiotic adverse events in the U.S. were not available. This investigation is the first to use timely, nationally representative surveillance data to estimate and compare the numbers and rates of adverse events from systemic antibiotics by class, drug, and event type. Half of the visits were for reactions to penicillins and the other half were from reactions to other antibiotics used to treat a wide variety of bacterial infections. After accounting for how often antibiotics were prescribed, children less than one year old were found to have the highest rate of adverse drug events. Almost 80 percent of all antibiotic adverse events in the study were allergic reactions, ranging from rash to anaphylaxis, and the remaining 20 percent were caused by errors and overdoses. Unlike errors and overdoses from other drugs, allergic reactions to antibiotics typically can only be prevented by avoiding exposure to the drug in the first place. The study draws from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance (NEISS-CADES) project, a sample of 63 hospitals in the United States and its territories. NEISS-CADES is a joint effort of the CDC, the United States Consumer Product Safety Commission, and the Food and Drug Administration. Previous studies have suggested that half of the estimated 100 million antibiotic prescriptions written in the community setting each year for respiratory tract infections may be unnecessary. "For conditions in which antibiotics have questionable benefit, such as many mild upper respiratory tract infections, weighing the benefits of antibiotics with the risks of a serious adverse event will be especially important," said Budnitz. "Because antibiotics are frequently used, both appropriately and inappropriately, if doctors would reduce the number of antibiotics they prescribe to their patients by even a small percentage, we could significantly reduce the number of emergency visits for antibiotic adverse events. Physicians need to communicate to their patients that antibiotics are not harmless," he added. The researchers found that only 6 percent of the patients who experienced adverse events required hospitalization. The others were all treated and released. However, the study only reflected emergency department admissions. Unreported cases and visits to a physician's office could not be taken into account. Infectious Diseases Society of America |
|||||||||||||||||||||
| Related Antibiotics Current Events and Antibiotics News Articles New study finds MRSA on the rise in hospital outpatients The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases. A Second Skin Despite advances in treatment regimens and the best efforts of nurses and doctors, about 70% of all people with severe burns die from related infections. Study reveals why certain drug combinations backfire Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. New imagining technique could lead to better antibiotics and cancer drugs A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist. UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin. Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Henry Ford Hospital study: A MRSA strain linked to high death rates A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study. Bacteria 'launch a shield' to resist attack Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system. Pumpkin skin may scare away germs The skin of that pumpkin you carve into a Jack-o'-Lantern to scare away ghosts and goblins on Halloween contains a substance that could put a scare into microbes that cause millions of cases of yeast infections in adults and infants each year. Deadly stomach infection rising in community settings, Mayo Clinic study finds Mayo Clinic researchers have found that a sometimes deadly stomach bug, Clostridium difficile is on the rise in outpatient settings. More Antibiotics Current Events and Antibiotics News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||